


CDC Faces Tumultuous Shake-up as Key Leaders Depart Amid New Nomination
Five high-level leaders depart the CDC a day after Trump's nomination of Susan Monarez as director, raising questions about agency stability and trust.
Overview
The CDC is undergoing significant upheaval following the announcement of five high-level departures, described as retirements, that occurred on Tuesday. This follows earlier losses, totaling nearly a third of the agency’s top management in recent weeks. The departures come just as President Trump nominated Susan Monarez as the permanent CDC director. Amid growing concerns over public trust in the CDC, particularly regarding vaccine safety, Monarez will face challenges in restoring confidence while navigating potential staff reductions and organizational changes proposed by the Trump administration.
Content generated by AI—learn more or report issue.

Get both sides in 5 minutes with our daily newsletter.
Analysis
- Susan Monarez has been nominated by President Trump as the new permanent director of the CDC after serving as acting director since January.
- Monarez's selection comes after the withdrawal of Trump’s previous nominee, David Weldon, due to concerns about his vaccination views and ability to be confirmed.
- If confirmed, Monarez will face Senate scrutiny regarding her prior actions at the CDC and the agency's handling of public health issues.
Articles (12)
Center (7)
FAQ
No FAQs available for this story.
History
- 3M4 articles